title: [Water in oil microemulsions for transdermal delivery of fluorouracil].
abstract: An Aersol-OT (AOT) included microemulsion containing fluorouracil was prepared by using appropriate proportion of oil, co-surfactant and water for increasing the drug transdermal delivery ability. According to the area of microemulsion basing on the pseudo-tertiary phase diagrams, the optimum formulation was screened initially. And the permeation flux of fluorouracil across excised mice skin was determined in vitro using Franz diffusion cell to optimize the formulation further. The effect of the kind of co-surfactant, the content of water, the content of mixed surfactant, the mass ratio of surfactant/cosurfactant (Km) and the drug load on skin permeation of fluorouracil were evaluated. The optimum formulation was composed of 0.5% (w/v) fluorouracil, 30% water, 20% mix-surfactant (AOT/Tween 85, Km = 2) and 49.5% oil (IPM). The cumulative amount permeated of fluorouracil in 12 hour was 1 355.5 microg x cm(-2), 19.1 folds and 7 folds more than 0.5% fluorouracil aqueous solution and 2.5% (w/w) fluorouracil cream, respectively. The permeation of this microemulsion accorded with first-order model. The water/AOT/Tween 85/IPM microemulsion system promoted the permeation of fluorouracil greatly, which may be a promising vehicle for the transdermal delivery of fluorouracil and other hydrophilic drug.
authors.affiliation: Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.forename: Yan-yu
authors.initials: YY
authors.lastname: Xiao
authors.forename: Qi-neng
authors.initials: QN
authors.lastname: Ping
authors.forename: Chuang
authors.initials: C
authors.lastname: Yang
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004337:Drug Carriers; D016503:Drug Delivery Systems / Q000379:methods*; D004655:Emulsions; D005472:Fluorouracil / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008297:Male; D051379:Mice; D009226:Myristates / Q000737:chemistry; D009821:Oils / Q000737:chemistry; D011136:Polysorbates / Q000737:chemistry; D012869:Skin Absorption; D013386:Succinates / Q000737:chemistry; D013501:Surface-Active Agents / Q000737:chemistry; D014867:Water / Q000737:chemistry
chemical_list: C512554:1,4-bis(2-ethylhexyl) sodium sulfosuccinate; D000964:Antimetabolites, Antineoplastic; D004337:Drug Carriers; D004655:Emulsions; D009226:Myristates; D009821:Oils; D011136:Polysorbates; D013386:Succinates; D013501:Surface-Active Agents; D014867:Water; C008205:isopropyl myristate; D005472:Fluorouracil